Emanuele Zucca, MD^1,2,3, Luca Ceriani, MD^4*, Andrew S. Davies, BSc (Hons) BM (Hons) PhD FRCP^5*, Giovannino Ciccone, MD^6*, Umberto Ricardi, MD^7*, Alice Di Rocco^8*, Iryna Kryachok, MD^9*, Barbara Botto^10*, Monica Balzarotti, MD^11*, Alessandra Tucci, MD¹², Vittorio Ruggero Zilioli^13*, Sara Usai, MD^14*, Luca Arcaini^15*, Elsa Pennese, MD^16*, Anna Dabrowska-Iwanicka, MD^17*, Andrés José María Ferreri, MD¹⁸, Franceso Merli, MD^19*, Wei Li Zhao, MD²⁰, David Hodgson, MD^21*, Codruta Ionescu, MD^22*, Luigi Rigacci, MD^23*, Claudia Cellini, MD^24*, Caterina Stelitano^25*, Stefano Volpetti, MD^26*, Carla Minoia, MD^27*, Michele Spina, MD^28*, Alexander Fossa, MD^29*, George Mikhaeel, MD^30*, Kate Cwynarski, MBBS, PhD, FRCP, FRCPath^31*, Andrea Janikova, Asoc. prof., PhD, MD^32*, Yana Stepanishyna, PhD MD^33*, Mats Jerkeman, MD, PhD³⁴, Andreas Huettmann, MD^35*, Maria Gomes da Silva, MD^36*, Don A. Stevens, MD³⁷, Sally F Barrington, MD^38*, Bogdan Małkowski, MD^39*, Ur Metser, MD, FRCPC^40*, Annibale Versari, MD^41*, Stephane Chauvie, PhD^42*, Oreste Bagni, MD^43*, Kelly Cozens^44*, Sonia Perticone^45*, Nicoletta Ielmini^46*, Letizia Deantonio, MD^47*, Jan Walewski, MD^48*, Marek Trneny, Prof., MD, PhD⁴⁹, Mary Gospodarowicz, MD^50*, Franco Cavalli, MD^46*, Peter Johnson, MD, FRCP^51* and Maurizio Martelli^52*

¹Division of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale, Bellinzona, Switzerland
²International Extranodal Lymphoma Study Group, Institute of Oncology Research, Bellinzona, Switzerland
³Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland
⁴Imaging Institute of Southern Switzerland (IIMSI), Lugano, Switzerland
⁵Southampton General Hospital, Southampton CRUK/NCRI Experimental Cancer Medicines Centre, Southampton, United Kingdom
⁶SSD Epidemiologia Clinica e Valutativa, AOU Città della Salute e della Scienza e CPO Piemonte, Torino, Italy
⁷Department of Oncology, University of Torino, Torino, Italy
⁸Department of Cellular Biotechnology and Haematology, Sapienza University, Rome, Italy
⁹National Cancer Institute, Kiev, Ukraine
¹⁰SC Ematologia, AOU Città della Salute e della Scienza, Torino, Italy
¹¹Humanitas Research Hospital IRCCS, Rozzano Milano, Italy
¹²Hematology, ASST Spedali Civili, Brescia, Italy
¹³Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
¹⁴Ospedale Oncologico Armando Businco, Cagliari, ITA
¹⁵Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹⁶Centro diagnosi e terapia dei linfomi, Presidio Ospedaliero Spirito Santo, Pescara, Italy
¹⁷Maria Sklodowska-Curie Memorial Cancer Center, Warshaw, Poland
¹⁸Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
¹⁹Hematology Department, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy
²⁰Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
²¹Princess Margaret Hospital, Toronto, ON, Canada
²²Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
²³Hematology Department, Policlinico Careggi, Firenze, Italy
²⁴Oncohematology Department, AUSL Romagna, Ravenna, Italy
²⁵Hematology, Hospital of Reggio Calabria, Italy, Reggio Calabria, Italy
²⁶Hematology Department, Azienda sanitaria universitaria Friuli Centrale, Udine, Italy
²⁷Clinical and Experimental Oncology Department, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy
²⁸Division of Medical Oncology, IRCCS Centro Di Riferimento Oncologico, Aviano, Italy
²⁹Department of Oncology, Oslo University Hospital, Oslo, Norway
³⁰Guy's Cancer Centre, Guy's & St Thomas' NHS Trust and King's College University, London, United Kingdom
³¹Department Of Hematology, Royal Free Hospital, London, United Kingdom
³²University Hospital Brno, Brno, Czech Republic
³³National Cancer Institute, Kyev, Ukraine
³⁴Lund University Hospital, Lund, Sweden
³⁵Department of Hematology, Essen University Hospital, Essen, Germany
³⁶Department of Hematology, Portuguese Institute of Oncology, Lisbon, Portugal
³⁷Norton Cancer Institute, Louisville, KY
³⁸School of Biomedical Engineering and Imaging Sciences, King’s College London and Guy’s and St Thomas’ PET Centre, London, United Kingdom
³⁹Department of Nuclear Medicine, Nicolaus Copernicus University, Torun, Poland
⁴⁰Department of Medical Imaging, University Health Network Princess Margaret Hospital, Toronto, ON, Canada
⁴¹Nuclear Medicine - Oncology and High Technology Dept - Director, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy
⁴²Medical Physics Division, AO Santa Croce e Carle, Cuneo, Italy
⁴³Nuclear medicine Department, ASL Latina, Latina, Italy
⁴⁴Southampton Clinical Trials Unit, Southampton General Hospital, Southampton, United Kingdom
⁴⁵Fondazione Italiana Linfomi Onlus, Alessandria, Italy
⁴⁶Institute of Oncology Research (IOR), Bellinzona, Switzerland
⁴⁷Radio-Oncology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
⁴⁸Lymphoma Department, MSCM Cancer Center, Warszawa, Poland
⁴⁹First Dept. of Internal Medicine- Hematology, General University Hospital, Charles University, Prague, Czech Republic
⁵⁰University Health Network Princess Margaret Hospital, Toronto, ON, Canada
⁵¹Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
⁵²UO Oncologia, Policlinico Umberto I - Università La Sapienza, Roma, Italy

Yuqin Song, MD¹, Zengjun Li^2*, Ling Li^3*, Zhengzi Qian^4*, Keshu Zhou, MD^5*, Lei Fan^6*, Peter Tan^7*, Pratyush Giri, MBBS^8*, Zhiming Li^9*, Melita Kenealy^10*, Jie Jin¹¹, Wei Liu, MD^12*, Shafqat Inam^13*, Yan Xie^14*, Xia Guo^15*, Wenduo He^15*, Raymond Xu^15*, Tong Li^15* and Jun Zhu^14*

¹Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China
²Department of Lymphoma and Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan, Shandong, China
³Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
⁴Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁵Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
⁶Jiangsu Province Hospital, Nanjing, Jiangsu, China
⁷One Clinical Research, Nedlands, Australia
⁸Royal Adelaide Hospital, Adelaide, Australia
⁹Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
¹⁰Cabrini Hospital, Melbourne, AUS
¹¹The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
¹²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
¹³Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, VIC, Australia
¹⁴Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Minis-try of Education), Peking University Cancer Hospital & Institute, Beijing, China
¹⁵Genor Biopharma Co., Ltd., Shanghai, China

Muhit Ozcan, MD^1*, Fangfang Lv^2*, Lalita Norasetthada^3*, Ewa Paszkiewicz-Kozik^4*, Joaquin Díaz Schmidt^5*, Dipenkumar Modi, MD⁶, Alexander Fosså, MD^7*, Sagun Goyal^8*, Won Seog Kim, MD, PhD^9*, Seung Tae Lee, MD¹⁰, Armando Santoro, MD^11*, Mehmet Sonmez^12*, Kumudu Pathiraja^13*, Nishitha Reddy^13*, Patricia Marinello, PharmD¹³ and Yuqin Song^14*

¹Ankara University School of Medicine, Ankara, Turkey
²Fudan University Shanghai Cancer Center, Shanghai, China
³Chiang Mai University, Chiang Mai, Thailand
⁴Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
⁵Clínica Alemana de Santiago, Santiago, Chile
⁶Barbara Ann Karmanos Cancer Institute, Detroit, MI
⁷Oslo universitetssykehus, Radiumhospitalet, Oslo, Norway
⁸Saint Louis University Cancer Center, St. Louis, MO
⁹Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
¹⁰University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
¹¹Humanitas University, Pieve Emanuele and IRCCS Humanitas Research Hospital- Humanitas Cancer Center Rozzano, Milan, Italy
¹²Karadeniz Teknik Universitesi Tip Fakultesi-Hematology, Trabzon, Turkey
¹³Merck & Co., Inc., Rahway, NJ
¹⁴Peking University Cancer Hospital and Institute, Beijing, China

Jason Westin, MD¹, Ranjit Nair, MD², Luis Fayad, MD³, Swami P. Iyer, MD⁴, Luis Malpica, MD^4*, Sattva S. Neelapu, MD⁵, Felipe Samaniego, MD^5*, Raphael Eric Steiner, MD⁶, Paolo Strati, MD⁷, Shivon Mathew, RN^8*, Donna Griffith^8*, Loretta J. Nastoupil, MD⁹, Wirt Montinez^8*, Maria Alma Rodriguez, MD^4*, Frederick Hagemeister^10*, Lei Feng, MS^11*, Francisco Vega, MD, PhD¹², Christopher R. Flowers, MD, MS⁷ and Sairah Ahmed, MD⁷

¹Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
³Lymphoma/Myeloma, M.D. Anderson Cancer Center, Houston, TX
⁴Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵M.D. Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX
⁹MD Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Cente, Houston, TX
¹¹Biostatistics, UT MD Anderson Cancer Center, Houston, TX
¹²Department of Hematopathology, MD Anderson Cancer Center , Houston, TX

Wei Liu, MD^1*, Yunhong Huang^2*, Haiyan Yang^3*, Zhiming Li^4*, Zhen Cai^5*, Zhen Wang, MD^6*, Lihong Liu^7*, Ye Guo^8*, Ligen Liu^9*, Rui Huang, MD^10*, Xu Ye, M.D., Ph.D.^11* and Lugui Qiu¹

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
²The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
³Zhejiang Cancer Hospital, Hangzhou, China
⁴State Key Laboratory of Oncology in South China, Guangzhou, China
⁵Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁶Linyi Cancer Hospital, Linyi, China
⁷The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
⁸Shanghai East Hospital, Shanghai, China
⁹Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
¹⁰Zhujiang Hospital of Southern Medical University, Guangzhou, China
¹¹Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

Steven I. Park, MD¹, Lakshmi Nayak, MD^2*, Danielle Boselli, MS^3*, Raphael E Steiner, MD^4*, Ashley L Sumrall, MD^5*, Nazanin K Majd, MD^6*, Xhevahire Begic^7*, Sarah Norek^7* and Christopher Dittus, DO⁸

¹Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
²Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston
³Department of Biostatistics and Data Sciences, Atrium Health Levine Cancer Institute, Charlotte, NC
⁴Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston
⁵Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, Charlotte
⁶Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston
⁷Sponsored Research Coordinating Center, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁸Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC

Ken Ohmachi, MD^1*, Tomohiro Kinoshita², Dai Maruyama³, Gakuto Ogawa^4*, Yusuke Sano, MD^5*, Nobuhiko Yamauchi, MD^6*, Noriko Fukuhara⁷, Toshiki Uchida, MD^8*, Kazuhito Yamamoto, MD, PhD^9*, Kana Miyazaki, MD, PhD¹⁰, Norifumi Tsukamoto, MD^11*, Shinsuke Iida¹², Isao Yoshida, MD, PhD^13*, Yasuhiro Suzuki, MD, PhD^14*, Yasufumi Masaki, MD, PhD¹⁵, Tohru Murayama, MD^16*, Yoshihiro Yakushijin, MD, PhD¹⁷, Youko Suehiro, MD, PhD^18*, Kisato Nosaka, MD¹⁹, Nobuaki Dobashi, MD²⁰, Junya Kuroda, MD, PhD²¹, Wataru Munakata^22*, Kiyoshi Ando^1*, Kenichi Ishizawa, MD, PhD^23*, Michinori Ogura, MD, PhD²⁴, Tadashi Yoshino, MD, PhD^25*, Tomomitsu Hotta, MD, PhD^26*, Kunihiro Tsukasaki, MD, PhD^6*, Kensei Tobinai, MD, PhD²⁷ and Hirokazu Nagai, MD, PhD²⁸

¹Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
²Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan
³Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
⁴JCOG Data Center, National Cancer Center Hospital, Tokyo, Japan
⁵JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan
⁶Department of Hematology, National Cancer Center Hospital East, Kashiwa, Japan
⁷Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
⁸Department of Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan
⁹Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, JPN
¹⁰Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, JPN
¹¹Department of Hematology, Gunma University Grad. School of Med., Maebashi, JPN
¹²Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
¹³Department of Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Mastuyama, Japan
¹⁴Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, JPN
¹⁵Department of Hematology and Immunology, Medicine, Kanazawa Medical University, Kahoku-Gun, JPN
¹⁶Dept. Hematology, Hyogo Cancer Center, Akashi, Japan
¹⁷First Department of Internal Medicine, Ehime University Graduate School of Medicine, Toon, JPN
¹⁸Department of Hematology and Cell Therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
¹⁹Cancer Center, Kumamoto University School of Medicine, Kumamoto, Japan
²⁰Department of Clinical Oncology and Hematology, The Jikei University Daisan Hospital, Komae, Tky, JPN
²¹Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan
²²Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
²³Department of Hematology, Tohoku University Hospital, Sendai, JPN
²⁴Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
²⁵Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
²⁶Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
²⁷Department of Hematology, National Cancer Center Hospital, Tokyo, Tky, JPN
²⁸Department of Hematology and Oncology Research, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan

Armando Santoro, MD^1*, Nathalie A. Johnson, MD, PhD,², Kerry J. Savage, MD, MSc, BSc³, Abraham Avigdor, MD⁴, Ali Bazargan, MD⁵, Peter Borchmann⁶, Robin Gasiorowski, MA, FRACP, FRCPA, MBBS⁷, Gareth P. Gregory⁸, Yair Herishanu^9*, Sumit Madan, MD¹⁰, Leonard Minuk, MD, FRCPC¹¹, Gerardo Musuraca, MD, PhD^12*, Rachel Marceau West^13*, Pallavi Pillai, MD¹³, Patricia Marinello, PharmD¹³ and Pier Luigi Zinzani, MD, PhD^14,15

¹Humanitas University, Pieve Emanuele and IRCCS Humanitas Research Hospital-Humanitas Cancer Center Rozzano, Milan, Italy
²Jewish General Hospital, Montreal, QC, Canada
³Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada
⁴Sheba Medical Center–Tel HaShomer, Ramat Gan, Israel
⁵University of Melbourne, Melbourne, St Vincent's Hospital, Fitzroy, VIC, Australia
⁶University Hospital Cologne, Cologne, Germany
⁷Concord Hospital, University of Sydney, Concord, NSW, Australia
⁸School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia
⁹Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel
¹⁰Banner MD Anderson Cancer Center, Gilbert, AZ
¹¹CancerCare Manitoba and University of Manitoba, Winnipeg, MB, Canada
¹²IRCCS Istituto Romagnolo per lo studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
¹³Merck & Co., Inc., Rahway, NJ
¹⁴IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli”, Bologna, Italy
¹⁵Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy

Thomas Chan, MD^1* and Eric Tse, PhD, MBBS²

¹Queen Mary Hospital, Hong Kong, Hong Kong
²University of Hong Kong, Queen Mary Hospital, Hong Kong, HKG

Anthony N. Audino, MD¹, Stanton Goldman, MD^2*, Matthew J. Barth, MD^3*, Jessica Hochberg, MD^4*, Ana C. Xavier, MD⁵, Bruce Shiramizu, MD^6*, Qiuhu Shi, PhD^4*, Lauren Harrison, MSN, RN^7*, Jackie Basso^4*, Javier Oesterheld, MD^8*, Kenneth Matthew Heym, MD^9*, Richard A. Drachtman, MD¹⁰, Paul Harker-Murray, MD, PhD¹¹, Sherrie L. Perkins, MD, PhD^12*, Rodney R. Miles, MD, PhD¹³ and Mitchell S. Cairo, MD^{14,15,16,17,18}

¹Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH
²Medical City Children's, Dallas, TX
³Roswell Park Cancer Institute, Buffalo, NY
⁴New York Medical College, Valhalla, NY
⁵University of Alabama at Birmingham, Vestavia Hills, AL
⁶University of Hawaii, Honolulu, HI
⁷New York Medical College, Valhall, NY
⁸Levine Children's Hospital, Charlotte, NC
⁹Department of Pediatrics, Cook Children's Medical Center, Fort Worth, TX
¹⁰Rutgers Cancer Institute New Jersey, New Brunswick, NJ
¹¹Midwest Children's Cancer Center, Milwaukee, WI
¹²University of Utah Health Sciences Center, Salt Lake City, UT
¹³University of Utah, Salt Lake City, UT
¹⁴Department of Medicine, New York Medical College, Valhalla, NY
¹⁵Department of Pediatrics, New York Medical College, Valhalla, NY
¹⁶Department of Epidemiology and Community Health, New York Medical College, Valhalla, NY
¹⁷Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY
¹⁸Department of Pathology/Microbiology and Immunology, New York Medical College, Valhalla, NY

Pio Manlio Mirko Frascione, MD^1*, Mattia Novo, MD^2*, Alessia Castellino, MD^3*, Luigi Marcheselli^4*, Samantha Deianira Dattoli^4*, Alessandra Tucci, MD⁵, Guido Gini, MD^6,7, Giuseppe Tarantini, MD^8*, Donato Mannina, MD^9*, Annalisa Arcari, MD^10*, Roberta Martiniani^11*, Elisabetta Scarpa^12*, Dario Marino, MD, PhD^13*, Michele Spina, MD^14*, Ausilia Giuseppa Gorgone^15*, Nicola Di Renzo, MD^16*, Salvatrice Mancuso^17*, Luigi Petrucci, MD^18*, Agostino Tafuri, MD¹⁹ and Umberto Vitolo, MD²⁰

¹Onco-Ematologia, Candiolo Cancer Institute- Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, AL, Italy
²Hematology Division, A.O.U Città della Salute e della Scienza di Torino, Torino, Italy
³Hematology Unit, Santa Croce e Carle Hospital, Cuneo, Piemonte, ITA
⁴Fondazione Italiana Linfomi, Clinical Trial Office, Modena, Italy
⁵Hematology, ASST Spedali Civili, Brescia, Italy
⁶Hematology Unit, AOU delle Marche-Università Politecnica delle Marche, Ancona, Italy
⁷Clinica Di Ematologia Università Politecnica Delle Marche- Ospedali Riuni, Ancona, ITA
⁸Haematology, Ospedale "Mons. Dimiccoli", Barletta, Italy
⁹Division of Hematology, Azienda Ospedaliera Papardo, Messina, Messina, Italy
¹⁰Division of Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy
¹¹University of Perugia, Terni, ITA
¹²Hematology, Ca Foncello Hospital, Treviso, ITA
¹³Oncologia 1, IRCCS Istituto Oncologico Veneto, Padova, Italy
¹⁴Division of Medical Oncology, IRCCS Centro Di Riferimento Oncologico, Aviano, Italy
¹⁵Hematology Department, G. Garibaldi Hospital, Catania, Italy
¹⁶Haematology, Ospedale V. Fazzi, Lecce, Italy, Lecce, Italy
¹⁷Policlinico Paolo Giaccone, Unit of Haematology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo, Palermo, Italy
¹⁸Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Roma, ITA
¹⁹Azienda Ospedaliera Sant'Andrea, Rome, Italy
²⁰Onco-Ematologia, Candiolo Cancer Institute- Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy

Julie M. Vose, MD, MBA¹, Tatyana Feldman, MD^2*, Martine E.D. Chamuleau, MD PhD³, Won Seog Kim, MD^4*, Pieternella Lugtenburg, MD, PhD⁵, Tae Min Kim, MD, PhD^6*, Pau Abrisqueta Costa, MD, PhD^7*, Chan Y. Cheah, MBBS, FRACP, FRCPA, DMSc⁸, Ingrid Cecilia Glimelius, MD, PhD^9*, Brian Hess, MD¹⁰, Wojciech Jurczak, MD, PhD¹¹, Gerardo Musuraca, MD, PhD^12*, Adam J. Olszewski, MD^13*, Minh Dinh, MD^14*, Nurgul Kilavuz, PharmMS^15*, Monica Wielgos-Bonvallet, PhD^15*, Tommy Li, PhD^15*, Zhu Li, PhD^15*, Christian Eskelund, MD, PhD^16* and Umar Farooq¹⁷

¹University of Nebraska Medical Center, Omaha, NE
²John Theurer Cancer Center at Hackensack Meridian Health, HMH School of Medicine, Hackensack, NJ
³On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Amsterdam UMC, VU University Medical Center,, Amsterdam, Netherlands
⁴Samsung Medical Center, Center for Hematologic Malignancy, Seoul, Korea, Republic of (South)
⁵Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Rotterdam, Netherlands
⁶Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁷Hospital Universitario Vall d’Hebro, Barcelona, Spain
⁸Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia
⁹Cancer Precision Medicine, Uppsala University, Uppsala, Sweden
¹⁰Medical University of South Carolina, Charleston, SC
¹¹Dpt of Clinical Oncology, MSC National Research Institute of Oncology, Kraków, Poland
¹²IRCCS Istituto Romagnolo per lo studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
¹³Lifespan Cancer Institute, The Warren Alpert Medical School of Brown University, Providence, RI
¹⁴AbbVie, North Chicago, IL
¹⁵Genmab, Plainsboro, NJ
¹⁶Genmab, Copenhagen, Denmark
¹⁷Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa City, IA

Geoffrey P. Shouse, PhD, DO¹, Leslie L. Popplewell, MD, FACP, MPH², Alex Muir, RN, BSN^3*, Tanya Siddiqi, MD⁴, Alex F. Herrera, MD⁵, Olga Danilova, MD, PhD^5*, Sandrine Puverel, PhD^3*, Lili Wang, MD/PhD⁶, Adam S Kittai, MD⁷, Lu Chen, PhD^8*, Matthew S. Davids, MD, MMSc⁹ and Alexey Danilov, MD¹⁰

¹Hematology/HCT, City of Hope National Medical Center, Duarte, CA
²Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
³City of Hope National Medical Center, Duarte, CA
⁴City of Hope, Irvine, CA
⁵City of Hope, Duarte, CA
⁶Department of Systems Biology, City of Hope Comprehensive Cancer Center, Duarte, CA
⁷Division of Hematology, The Ohio State University, Columbus, OH
⁸Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
⁹Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
¹⁰Department of Hematology and HCT, City of Hope National Medical Center, La Canada Flintridge, CA

Koji Izutsu, MD, PhD¹, Kenji Ishitsuka, MD, PhD^2*, Dai Maruyama, MD, PhD¹, Kunihiro Tsukasaki, MD, PhD³, Shigeru Kusumoto, MD, PhD⁴, Yasuyuki Kakurai, PhD^5*, Hideyuki Yamauchi, MSc^5*, Ai Inoue, MD, PhD^6*, Masaya Tachibana, PhD^5*, Shinji Tsutsumi, PhD^6* and Kensei Tobinai, MD, PhD¹

¹National Cancer Center Hospital, Tokyo, Japan
²Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan
³Department of Hematology, Saitama Medical University International Medical Center, Saitama, Japan
⁴Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
⁵Daiichi Sankyo Co., Ltd., Tokyo, Japan
⁶Daiichi Sankyo Inc., Basking Ridge, NJ

Zhiming Li^1*, Peng Sun^2*, Hong Cen^3*, Haiyan Yang^4*, Rui Huang, MD^5*, Zhen Cai^6* and Xuekui Gu^7*

¹Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
²Sun Yat-sen University Cancer Center, Guangzhou, China
³Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China
⁴Zhejiang Cancer Hospital, Hangzhou, China
⁵Department of Hematology, Zhujiang Hospital, Southern Medical University, GUANGZHOU, AL, China
⁶The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
⁷The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China

Gilles Salles, MD, PhD¹, Christopher P. Fox, MD, PhD², Anthony Wang, MPH, PhD^3*, Kavita Sail, PhD^4*, Abualbishr Alshreef, MPH, MSc, PhD^5*, Michael Moran, MD, PhD^4*, Alex Mutebi, PhD^6*, Julie Blaedel, MD^6*, Viktor Chirikov, MS, PhD^7*, Wei-Jhih Wang, MS, PhD^7* and Catherine Thieblemont, MD^8*

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Haematology, Nottingham City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
³AbbVie, Inc., Chicago, IL
⁴AbbVie Inc., North Chicago, IL
⁵AbbVie, Inc., Maidenhead, United Kingdom
⁶Genmab US, Inc., Plainsboro, NJ
⁷OPEN Health, Bethesda, MD
⁸Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France

Thomas Melchardt, MD^1,2*, Rebecca I Wurm-Kuczera^3*, Bettina Altmann, PhD^4*, Petra Pichler, MD^5*, Manuel Orlinger, MD^6*, Michael Panny^7*, Luisa Wohn^8*, Andreas Rosenwald, MD^9*, Dirk Hellwig, MD^10*, Sascha Dietrich, MD^11*, Bertram Glass, MD, PhD^12*, Georg Lenz¹³, Ulrich Keller^3*, Marita Ziepert, PhD^4*, Richard Greil, MD^2,14 and Bjoern Chapuy, MD³

¹Medizin III, mit Hämatologie, internistischer Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum; Paracelsus Medizinische Universität, Salzburg, Austria
²Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT); Cancer Cluster Salzburg, Salzburg, Austria
³Department of Hematology, Oncology and Tumor Immunology, Charité - University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany
⁴Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig, Germany
⁵Department of Internal Medicine I: Hematology & Oncology, University Hospital St. Poelten, Karl Landsteiner University of Health Sciences, St. Poelten, Austria
⁶Barmherzige Schwestern Hospital Linz, Linz, Austria
⁷Hanusch Hospital Wien, Wien, Austria
⁸Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Frankfurt Am Main, Germany
⁹Institute of Pathology, Julius-Maximilians-Universität Würzburg, Wuerzburg, Germany
¹⁰Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany
¹¹Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany
¹²Klinik für Hämatologie und Zelltherapie, Helios Klinik Berlin-Buch, Berlin, Germany
¹³Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
¹⁴Universitätsklinik für Innere Medizin III, mit Hämatologie, internistischer Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum; Paracelsus Medizinische Universität, Salzburg, Austria

Jennifer L Crombie, MD¹, Austin I Kim, MD², Nancy L. Bartlett, MD³, Robert A. Redd, MS^4*, Victoria Patterson, BSN, RN^5*, Celeste Carey^5*, Sobana Balasubramanian^5*, Oreofe O. Odejide, MD, MPH⁵, Reid W. Merryman, MD⁵, Ann LaCasce, MD⁵, Caron A Jacobson, MD, MMSc⁵, Eric Jacobsen, MD⁵, Erin M Parry, MD, PhD⁶, David C Fisher, MD⁵, Alex F. Herrera, MD⁷, Matthew S. Davids, MD, MMSc⁶, Margaret A. Shipp, MD⁸, Philippe Armand, MD, PhD⁵ and Geoffrey P. Shouse, PhD, DO⁹

¹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Dana-Farber Cancer Institute, Boston
³Washington University Sch. of Med. Siteman Cancer Center, Saint Louis, MO
⁴Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁵Dana-Farber Cancer Institute, Boston, MA
⁶Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
⁷City of Hope, Duarte, CA
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁹Hematology/HCT, City of Hope National Medical Center, Duarte, CA

Wei Guo^1*, Xingtong Wang, MD², Yangzhi Zhao, MD/PhD^1*, Jia Li³, Chunshui Liu^4*, Xin Wan, MD^1* and Ou Bai, MD/PhD^1*

¹Department of Hematology, The First Hospital of Jilin University, Changchun, Jilin, China
²Department of Hematology, The First Hospital of Jilin University, Changchun, KY, China
³Department of Hematology, The First Hospital of Jilin University, Changchun, China
⁴Hematology, The First Hospital of Jilin University, Changchun, China

William G. Wierda, MD, PhD¹, Nirav N. Shah, MD², Chan Yoon Cheah, MD³, David Lewis, MBChB, PHD^4*, Marc Hoffmann, MD⁵, Catherine C. Coombs, MD⁶, Nicole Lamanna, MD⁷, Shuo Ma, MD, PhD⁸, Deepa Jagadeesh, MD⁹, Talha Munir, MBBS, MRCP, FRCPath, PhD^10*, Yucai Wang, MD, PhD¹¹, Toby A. Eyre^12*, Joanna M. Rhodes, MD¹³, Matthew McKinney, MD^14*, Ewa Lech-Maranda, MD, PhD^15*, Constantine S. Tam, MD, MBBS¹⁶, Wojciech Jurczak, MD, PhD¹⁷, Koji Izutsu, MD, PhD¹⁸, Alvaro J. Alencar, MD¹⁹, Manish Patel, MD^20*, John F. Seymour, MBBS, PhD, FRACP²¹, Jennifer A. Woyach, MD²², Lindsey E. Roeker, MD²³, Philip A. Thompson, MBBS^24*, Paolo Abada, MD²⁵, Caleb Ho, M.D.²⁵, Narasimha Marella, Ph.D.^25*, Chunxiao Wang, Ph.D.^26*, Amy S. Ruppert, PhD^26*, Binoj Chandrasekharan Nair, Ph.D.^25*, Hui Liu, Ph.D.^25*, Donald E. Tsai, MD, PhD^25* and Paolo Ghia, MD, PhD²⁷

¹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²Medical College of Wisconsin, Milwaukee, WI
³Linnear Clinical Research and Sir Charles Gairdner Hospital and University of Western Australia, Perth, Australia
⁴University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
⁵The University of Kansas Medical Center, Kansas City, KS
⁶University of California, Irvine, Irvine, CA
⁷Herbert Irving Comprehensive Cancer Center, Columbia University, New York
⁸Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
⁹Cleveland Clinic, Cleveland, OH
¹⁰Department of Haematology, St. James's University Hospital, Leeds, United Kingdom
¹¹Division of Hematology, Mayo Clinic, Rochester, MN
¹²Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
¹³Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
¹⁴Duke Cancer Institute, Durham, NC
¹⁵Institute of Hematology and Transfusion Medicine, Warsaw, Poland
¹⁶The Alfred Hospital and Monash University, Melbourne, VIC, Australia
¹⁷Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
¹⁸National Cancer Center Hospital, Tokyo, Japan
¹⁹Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
²⁰Florida Cancer Specialists, Sarah Cannon Research Institute, Sarasota, FL
²¹Peter MacCallum Cancer Center, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia
²²The Ohio State University Comprehensive Cancer Center, Columbus, OH
²³Memorial Sloan Kettering Cancer Center, New York, NY
²⁴Peter MacCallum Cancer Center, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia
²⁵Loxo@Lilly, Indianapolis, IN
²⁶Eli Lilly and Company, Indianapolis, IN
²⁷Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy